bioRxiv / medRxiv
open access
CC BY-NC-ND 4.0
Systems serology of responses against tumor antigens in ovarian cancer reveal disrupted Fc-mediated immunity
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer#184945
- Immune Repertoire of Ovarian HGSC#892543
- Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer#1113435
- QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy#394767
- The PVR-TIGIT/CD96/CD226 axis: a novel immune checkpoint target in ovarian cancer.#653460
Record · ID 234314
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive